Novo Nordisk announced it will cut Ozempic and Wegovy list prices by up to 50% starting in 2027
Not all studies required dilated fundus examinations or retinal imaging, and they differed in inclusion criteria that would affect risk for disease progression
Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability
These broader changes could have a wide-ranging impact on companies across numerous sectors including healthcare, pharmaceuticals, insurers, medical device companies, the food and beverage industry, retailers, fitness businesses, airlines and many more
A program like this should have a licensed provider review your intake weight, medical history, and medications before anything is prescribed, followed by visits that support titration and side-effect management
Malik S, et al